Sherbrooke Park Advisers’s Cytek Biosciences CTKB Stock Holding History

Sherbrooke Park Advisers’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$89.5K	Sell
2024 Q4	$271K	Sell
2024 Q3	$578K	Buy
2024 Q2	$167K	Sell
2024 Q1	$576K	Buy
2023 Q4	–	Sell
2023 Q3	$86.4K	Buy